The Private Clinic Group has acquired The Cosmetic Skin Clinic (CSC) with the backing of its private equity owner BlueGem Capital in a bid to create the UK’s leading ‘high-end’ cosmetic treatment provider.
Financial details of the transaction have not been disclosed but the combined group will have £30m in revenue and a 20% EBITDA margin in 2019.
CSC has clinics in Buckinghamshire and the Harley Street medical area. It specialises in cutting-edge non-surgical treatments and has been the leading provider of CoolSculpting® in UK and Western Europe for the past six years.
This is the latest in a series of acquisitions by The Private Clinic, which has doubled in size since it was bought by mid market private equity firm BlueGem in 2008. Revenue has grown from £4m to around £18m in the last decade as the company focused on consolidating the market and providing ‘five-star’, confidential treatment for VIP patients.
BlueGem co-founder and partner Emilio Di Spiezio Sardo and director Sarah Walker said: ‘We are delighted to announce the acquisition of The Cosmetic Skin Clinic by The Private Clinic Group. It is an excellent example of BlueGem’s approach to creating value in our portfolio companies, as we support them both financially and managerially to find the best growth solutions. Today’s acquisition further supports our vision to be the leading consolidator of premium cosmetics clinics in the UK, following previous acquisitions including Hans Place (2009), Regency Medical (2010) and Aurora Clinics (2016). The platform is very well positioned to continue this growth journey, via both organic growth and new buy-and-build opportunities.’
BlueGem and The Private Clinic were advised by EPIC, McDermott Will & Emery, Grant Thornton and Marlborough Partners. The Cosmetic Skin Clinic was advised by Farrer & Co and Glazers.